ACTC’s mission is to facilitate state-of the art AD/ADRD interventional trials by providing an optimal infrastructure, utilizing centralized resources, and leveraging shared expertise.
What type of research sites are invited to apply?
ACTC is looking for two categories of research sites:
- Category A – Member Sites: Sites with established track record of conducting AD/ADRD trials.
- Category B – Developmental/Exploratory Trial Sites: Sites with less experience in the conduct of AD/ADRD clinical trials interested in mentored opportunities through the consortium to establish rigorous programs in the conduct of these studies. Of particular interest for this category are sites with the leadership, staff, access, and relationships with communities who are typically under-represented in AD/ADRD trials.
What are the benefits of ACTC membership?
ACTC is the premier NIA-funded network of AD/ADRD trial sites.
Member sites:
- Annual infrastructure funding covers effort for the following four positions: 5% of the Principal Investigator (PI), 20% of a Co-PI (ideally an early or mid-career investigator), 50% of a Site Liaison, and 100% of a community outreach coordinator.
- Site PIs are voting members of the ACTC Steering committee, approve any new ACTC Study proposals, provide input and guidance on study design and conduct, and may even co-lead multisite trials.
- Site staff have opportunity and access to an array of resources and committee involvement opportunities, intended to enhance the quality of trial conduct for individual investigators, sites, and the network overall.
- ACTC developmental/exploratory sites receive annual infrastructure cost to cover effort for the following four positions: 5% PI, 5% co-PI, 25% site liaison, 100% community outreach coordinator. This effort will support the planning and establishment of the infrastructure to become an ACTC member site.
- Developmental/exploratory sites will receive formal mentoring from an ACTC mentoring committee, with the goal of building capacity to support and eventually participate in ACTC trials.
- Site staff have opportunity and access to an array of resources and committee involvement opportunities, intended to enhance the quality of trial conduct for individual investigators, sites, and the network overall.
- ACTC Member Sites must agree to a Master Clinical Trial Agreement and to use the single, central Institutional Review Board (IRB). Fixed trial budgets are utilized for ACTC studies across all sites. Budgets do have input from a committee.
- ACTC site personnel (member and developmental/exploratory sites) are expected to participate in three ACTC steering committee meetings each year to discuss ongoing and consider new consortium studies and initiatives.
- Member site funded personnel are also expected participate in ACTC committees, initiatives, and trials and actively engage in the consortium activities. Sites must meet minimum performance requirements to maintain financial support. Minimum performance requirements are established with input from the ACTC steering committee members and the ACTC site metrics and budget committee.
- Submit your application using this link: https://redcap.link/actc-new-sites. You will upload CVs for your application PI and co-PI and can save and return to the application if needed.
- Applications are due May 30, 2023. Applications are reviewed in June and selection will take place late June 2023, with subcontracts sent during July 2023.
- Studies we are conducting: https://www.actcinfo.org/projects/
- See our current member sites: https://www.actcinfo.org/member-sites/
- Contact ACTC Program Administrator via email: waltersa@usc.edu, or by phone: 858-531-7089.
